SLC5A2 and type 2 diabetes mellitus: Sugiyama et al. recently reported a case of a patient who completely recovered from T2DM after treatment with the SGLT2 inhibitor dapagliflozin and metformin, accompanied by an impressive reduction in baseline body weight [94].